We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.02B
1-Year Est. Return
53.92%
This Fund
S&P 500
This Quarter
Est. Return
+9.03%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$3.14B
AUM Growth
-$67M
(-2.1%)
Cap. Flow
-$232M
Cap. Flow
% of AUM
-7.39%
Top 10 Holdings %
Top 10 Hldgs %
17.34%
Holding
430
New
63
Increased
87
Reduced
126
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$36.9M |
| 2 |
Microchip Technology
MCHP
|
+$29.9M |
| 3 |
Costco
COST
|
+$24.9M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$23.6M |
| 5 |
Biogen
BIIB
|
+$17.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$33.1M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$27.6M |
| 3 |
ConocoPhillips
COP
|
+$26.9M |
| 4 |
Devon Energy
DVN
|
+$26.3M |
| 5 |
Walt Disney
DIS
|
+$25.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.61% |
| 2 | Healthcare | 15.64% |
| 3 | Consumer Discretionary | 13.94% |
| 4 | Industrials | 13.85% |
| 5 | Energy | 13.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ulta Beauty
ULTA
$21.8B
| $65.2M | 2.08% |
267,810
-22,360
| -8% | -$4.87M |
|
2
UnitedHealth
UNH
$385B
| $58.8M | 1.88% |
416,450
-8,060
| -2% | -$1.07M |
|
3
Home Depot
HD
$341B
| $57M | 1.82% |
446,500
+16,770
| +4% | +$2.22M |
|
4
GE Aerospace
GE
$365B
| $56.3M | 1.8% |
373,061
-31,113
| -8% | -$4.54M |
|
5
Salesforce
CRM
$154B
| $56M | 1.79% |
704,860
+23,120
| +3% | +$1.81M |
|
6
Edwards Lifesciences
EW
$49.1B
| $55.6M | 1.77% |
1,671,900
-158,640
| -9% | -$5.43M |
|
7
Meta Platforms (Facebook)
META
$1.5T
| $51.8M | 1.65% |
453,045
-34,600
| -7% | -$3.99M |
|
8
TransDigm Group
TDG
$71.4B
| $49M | 1.56% |
185,737
+6,490
| +4% | +$1.58M |
|
9
Bristol-Myers Squibb
BMY
$130B
| $48M | 1.53% |
652,570
+76,990
| +13% | +$5.44M |
|
10
Adobe
ADBE
$104B
| $45.9M | 1.46% |
478,920
-39,980
| -8% | -$3.84M |
|
11
Monster Beverage
MNST
$95.5B
| $44.7M | 1.43% |
1,668,450
+629,760
| +61% | +$15.2M |
|
12
Amazon
AMZN
$2.46T
| $43.4M | 1.38% |
1,213,400
+458,600
| +61% | +$15.5M |
|
13
CME Group
CME
$95.6B
| $42.9M | 1.37% |
440,040
-36,320
| -8% | -$3.43M |
|
14
EOG Resources
EOG
$77.2B
| $42.5M | 1.36% |
509,400
-117,620
| -19% | -$9.42M |
|
|
15
Devon Energy
DVN
$51.1B
| $41.2M | 1.32% |
1,137,840
-775,580
| -41% | -$26.3M |
|
|
16
Medtronic
MDT
$113B
| $39.9M | 1.27% |
459,790
+456,910
| +15,865% | +$36.9M |
|
17
Aptiv
APTV
$12.3B
| $38.2M | 1.22% |
610,990
+101,870
| +20% | +$7.12M |
|
|
PXD
18
DELISTED
Pioneer Natural Resource Co.
PXD
| $37.9M | 1.21% |
250,870
+45,500
| +22% | +$7.14M |
|
19
Alphabet (Google) Class C
GOOG
$4.09T
| $37.6M | 1.2% |
1,087,900
-685,700
| -39% | -$24.6M |
|
20
Tapestry
TPR
$30B
| $36.2M | 1.15% |
888,725
-207,975
| -19% | -$8.2M |
|
21
Visa
V
$709B
| $36M | 1.15% |
485,060
-40,470
| -8% | -$3.17M |
|
22
NXP Semiconductors
NXPI
$60.8B
| $35.7M | 1.14% |
456,050
-37,740
| -8% | -$3.24M |
|
|
CLR
23
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $35.3M | 1.13% |
779,900
-134,960
| -15% | -$5.3M |
|
24
Sherwin-Williams
SHW
$85.1B
| $35.1M | 1.12% |
358,440
-29,760
| -8% | -$2.9M |
|
25
Apple
AAPL
$5T
| $34.4M | 1.1% |
1,437,800
-475,220
| -25% | -$11.8M |
|
Similar funds
MCM
JIC
CFM
SM
TAM
KIA
BGDI
Castleark Management's Q2 2016 Portfolio in Review
As of Q2 2016, Castleark Management held 430 positions worth $3.14B, down 2.1% from $3.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Castleark Management withdrew a net $232M in Q2 2016, closing 57 positions and reducing 126 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $16M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Castleark Management opened a new position in Biogen worth $16.1M.
- Castleark Management's largest Q2 2016 buy was Biogen: 66,490 shares worth $16.1M.
- Castleark Management added most to Medtronic in Q2 2016, an estimated $36.9M increase.
- Castleark Management's biggest Q2 2016 reduction was Nike, cutting an estimated $33.1M.
- Castleark Management fully exited Nuance Communications, Inc. in Q2 2016, selling an estimated $16M.
- Castleark Management's ten largest holdings make up 17% of its $3.14B portfolio in Q2 2016.
- Castleark Management opened 63 new positions and closed 57 in Q2 2016.
- Castleark Management's portfolio value fell 2.1% quarter-over-quarter to $3.14B.
Based on Castleark Management's 13F filing for Q2 2016, filed 10 Aug 2016.